European Radiology ExperimentalBioinformaticsPeer-reviewed journal article
A prospectively validated machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma
Georgios A. KaissisiD, Sebastian ZiegelmayeriD, Fabian Karl LohöferiD, Hana AlgüliD, Matthias EiberiD, Wilko WeichertiD, Roland Michael SchmidiD, Helmut FriessiD, Ernst J. RummenyiD, Donna Pauler AnkerstiD, Jens Thomas SivekeiD, Rickmer BrareniD
Abstract
PurposeTo develop a supervised machine learning algorithm capable of predicting above vs. below-median overall survival from medical imaging-derived radiomic features in a cohort of patients with pancreatic ductal adenocarcinoma (PDAC).\n\nMaterials and Methods102 patients with histopathologically proven PDAC were retrospectively assessed as the training cohort and 30 prospectively enrolled patients served as the external validation cohort. Tumors were segmented in pre-operative diffusion weighted-(DW)-MRI derived ADC maps and radiomic features were extracted. A Random Forest machine learning algorithm was fit to the training cohort and tested in the external validation cohort. The histopathological subtype of the tumor samples was assessed by immunohistochemistry in 21/30 patients of the external validation cohort. Individual radiomic feature importance was evaluated.\n\nResultsThe machine learning algorithm achieved a sensitivity of 87% and a specificity of 80% (ROC-AUC 90%) for the prediction of above- vs. below-median survival on the unseen data of the external validation cohort. Heterogeneity-related features were highly ranked by the model. Of the 21 patients for whom the histopathological subtype was determined, 8/9 patients predicted by the model to experience below-median overall survival exhibited the quasi-mesenchymal subtype, while 11/12 patients predicted to experience above-median survival exhibited a non-quasi-mesenchymal subtype (Fishers exact test P<0.001).\n\nConclusionThe application of machine-learning to the radiomic analysis of DW-MRI-derived ADC maps allowed the prediction of overall survival with high diagnostic accuracy in a prospectively collected cohort. The high overlap of clinically relevant histopathological subtypes with model predictions underlines the potential of quantitative imaging workflows in pre-operative subtyping and risk assessment in PDAC.
- organism: human
- assay: imaging
- research focus: differential expression
- approach: machine learning (classical)
- Citations
- 79
- FWCI
- 8.58
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapy
Georgios A. Kaissis, Sebastian Ziegelmayer, … Rickmer Braren·PLoS ONEPeer-reviewed·Oct 2, 2019
- Computational discovery of tissue morphology biomarkers in very long-term survivors with pancreatic ductal adenocarcinoma
Jacob S. Sarnecki, Laura DeLong Wood, … Pei-Hsun Wu·bioRxiv·Oct 25, 2017
- DEVELOPMENT OF A CONSENSUS MOLECULAR CLASSIFIER FOR PANCREATIC DUCTAL ADENOCARCINOMA
Pablo Villoslada-Blanco, Lola Alonso, … Núria Malats·Genome MedicinePeer-reviewed·Nov 14, 2025
- PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides
C. Saillard, F. Delecourt, … J. Cros·bioRxiv·Jan 4, 2022
- MICLEAR: Intelligent Molecular Cytology for Intraoperative Margin Assessment of Pancreatic Ductal Adenocarcinoma
- Multiplex-GCN Predicts Clinically Actionable Tumor Microenvironment Subtypes in Pancreatic Cancer
Shayori Bose, Paramita Basak Upama, Sheikh Iqbal Ahamed·bioRxiv·Oct 28, 2026